| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12094-015-1405-9 |
| P698 | PubMed publication ID | 26459248 |
| P50 | author | Mehmet Aliustaoglu | Q56990885 |
| P2093 | author name string | A Bilici | |
| M Basar | |||
| D Yavuzer | |||
| D Aydin | |||
| S Kayahan | |||
| P2860 | cites work | Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer | Q39017695 |
| RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma | Q39120311 | ||
| Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma | Q39779862 | ||
| Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma. | Q40009864 | ||
| Ectopic expression of RASSF2 and its prognostic role for gastric adenocarcinoma patients | Q41878340 | ||
| Activation of RASSF2A by p300 induces late apoptosis through histone hyperacetylation | Q45293657 | ||
| RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level | Q45383714 | ||
| Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis. | Q46650545 | ||
| HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance. | Q50889414 | ||
| Japanese Classification of Gastric Carcinoma - 2nd English Edition - | Q51050338 | ||
| RAS oncogenes: the first 30 years. | Q55036584 | ||
| HER2 expression and its clinicopathological features in resectable gastric cancer | Q83629811 | ||
| Gastric cancer | Q84276928 | ||
| RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor | Q24301371 | ||
| Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences | Q24301831 | ||
| RASSF2 associates with and stabilizes the proapoptotic kinase MST2 | Q24338394 | ||
| RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer | Q24651245 | ||
| Gene methylation in gastric cancer | Q26991766 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations. | Q33213563 | ||
| Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer. | Q34168295 | ||
| Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma | Q34570584 | ||
| Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers | Q34570590 | ||
| The dark side of Ras: regulation of apoptosis | Q35603375 | ||
| Role of the Ras-association domain family 1 tumor suppressor gene in human cancers | Q36113844 | ||
| RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells | Q36216004 | ||
| Deregulated Ras signaling in developmental disorders: new tricks for an old dog. | Q36701563 | ||
| Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer | Q36818078 | ||
| The RASSF proteins in cancer; from epigenetic silencing to functional characterization | Q37432498 | ||
| Cancer type-specific epigenetic changes: gastric cancer | Q38271072 | ||
| P433 | issue | 6 | |
| P921 | main subject | gastrectomy | Q827390 |
| P304 | page(s) | 608-616 | |
| P577 | publication date | 2015-10-12 | |
| P1433 | published in | Clinical and Translational Oncology | Q15754324 |
| P1476 | title | Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy | |
| P478 | volume | 18 |
| Q90266334 | Machine Learning Classifiers for Endometriosis Using Transcriptomics and Methylomics Data | cites work | P2860 |
Search more.